NRIX Nurix Therapeutics Chart, History Price & Graph

• Overall Technical Rating: Neutral to buy signals across platforms, with TradingView indicating a buy rating and Investing.com showing strong sell on daily but buy on shorter terms.
• Trend: Upward bias in the intermediate term, with 5.33% gain over last 30 days and 60%+ over past year, trading above 200-day MA but testing 50-day MA.
• Key Levels: Support at 15.50 (pivot S2), 14.50; resistance at 16.18 (R1), 18.12 recent high, 22.50 52-week high.
• Momentum Indicators: RSI(14) around 42-52 neutral/sell, MACD positive buy signal at 0.11.
• Moving Averages: Price near 50-day MA (15.71-15.96), well above 200-day MA (13.68-15.46).

Trend Analysis

The chart of NRIX, shares of Nurix Therapeutics, Inc., a clinical-stage biopharmaceutical company, displays a sideways to mildly bullish trend in the short term within a broader uptrend. Over the last 30 days, the stock has gained approximately 5%, reflecting consolidation after a significant rebound. Year-to-date, it trades down modestly, but the 52-week range from 8.18 to 22.50 underscores volatility typical of biotech names. Recent price action shows the stock breaking above prior peaks around 18.12, suggesting potential continuation if sustained, though it has pulled back to test key averages amid neutral weekly and monthly signals.

Support and Resistance Levels

Traders are eyeing pivot-derived levels for near-term direction. Classic pivots place support at 15.67 (S1), 15.50 (S2), and 15.16 (S3), with resistance at 16.18 (R1), 16.52 (R2), and 16.69 (R3). Fibonacci levels align closely, with S1 at 15.82 and R1 at 16.20. Broader chart support emerges near 14.50 and the 200-day MA zone around 13.68-15.46, while overhead resistance looms at the recent high of 18.12 and the 52-week peak of 22.50. A blue box demand zone below current levels is noted as a potential buying area on pullbacks.

Moving Averages

NRIX hovers near its 50-day simple moving average of 15.71-15.96, with the price recently dipping below on daily charts, signaling short-term weakness. The exponential 50-day sits at 15.82 (sell). Longer-term, the stock remains above the 200-day simple moving average of 13.68-15.46 (buy signal), supporting the intermediate uptrend. Shorter MAs (5-20 day) at 15.98-16.24 indicate sell pressure, as the price trades below them, pointing to consolidation.

Momentum Indicators

RSI(14) at 42.38 registers in sell territory but approaching neutral, with prior readings near 50-52 indicating balanced momentum without extremes. STOCH(9,6) at 39.98 (sell) and oversold STOCHRSI at 0 suggest potential bounce. MACD(12,26) at 0.11 provides a buy signal, hinting at budding bullish divergence amid high volatility (ATR 0.40). Oversold readings in Williams %R (-95.50) and CCI (-227) reinforce watch for reversal.

Volume and Market Activity

Recent sessions show volume around 1.1-1.7 million shares, often 55-100% of the 1.14-1.17 million average, with spikes during rebounds. Elevated activity accompanies price tests of key levels, but no major spikes signal breakouts yet. Volume rising with price supports bullish ideas.

AI Daily Buy/Sell Signals

Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast market data, technical indicators, and recurring price patterns, generating actionable buy or sell signals for stocks like NRIX. These signals draw from trend detection, historical analogs, and momentum shifts to pinpoint potential entry/exit points, validate ongoing trends, and bolster decision-making frameworks. Traders rely on them for objective insights amid market noise, often combining with personal analysis for enhanced precision. Explore the AI signals to see how they align with NRIX’s chart dynamics.

Technical Outlook and Key Levels to Watch

Market participants monitor a hold above 15.50 support for bullish continuation toward 16.18-16.52 resistance, with confirmation above 18.12 eyeing higher targets. Breach below 15.16 could test 14.50 or 200-day MA. Watch MACD for sustained buy momentum, RSI for oversold relief, and volume for breakout conviction. Pivot zones and MA alignments remain focal points.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.